Cargando…
Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives.
Cyclosporin A (Sandimmune) increased the in vitro susceptibility of 'parental' and 'multidrug-resistant' (MDR) chinese hamster ovary (CHO) cell lines to three anti-tumour drugs: colchicine, daunomycin, and vincristine. Several immunosuppressive or non-immunosuppressive derivative...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247253/ https://www.ncbi.nlm.nih.gov/pubmed/2481487 |
_version_ | 1782150942428233728 |
---|---|
author | Gavériaux, C. Boesch, D. Boelsterli, J. J. Bollinger, P. Eberle, M. K. Hiestand, P. Payne, T. Traber, R. Wenger, R. Loor, F. |
author_facet | Gavériaux, C. Boesch, D. Boelsterli, J. J. Bollinger, P. Eberle, M. K. Hiestand, P. Payne, T. Traber, R. Wenger, R. Loor, F. |
author_sort | Gavériaux, C. |
collection | PubMed |
description | Cyclosporin A (Sandimmune) increased the in vitro susceptibility of 'parental' and 'multidrug-resistant' (MDR) chinese hamster ovary (CHO) cell lines to three anti-tumour drugs: colchicine, daunomycin, and vincristine. Several immunosuppressive or non-immunosuppressive derivatives of cyclosporin (Cs) were compared for their ability to sensitise both parental and MDR cells to chemotherapeutic agents. Although 5-10-fold increases of sensitivity to anti-tumour drugs could be obtained for cells of the parental line with several Cs-derivatives, the largest 'gains' of sensitivity (chemosensitisation) were obtained for the cells of the MDR line and with only some of the Cs derivatives. The MDR cells employed displayed the typical MDR phenotype. However, we found no correlation between the immunosuppressive activity of Cs derivatives and their capacity to reverse MDR and all four possible combinations of these two activities could indeed be shown among the tested Cs derivatives. This study demonstrates for the first time that some immunosuppressive Cs can be devoid of chemosensitising activity. |
format | Text |
id | pubmed-2247253 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1989 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-22472532009-09-10 Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives. Gavériaux, C. Boesch, D. Boelsterli, J. J. Bollinger, P. Eberle, M. K. Hiestand, P. Payne, T. Traber, R. Wenger, R. Loor, F. Br J Cancer Research Article Cyclosporin A (Sandimmune) increased the in vitro susceptibility of 'parental' and 'multidrug-resistant' (MDR) chinese hamster ovary (CHO) cell lines to three anti-tumour drugs: colchicine, daunomycin, and vincristine. Several immunosuppressive or non-immunosuppressive derivatives of cyclosporin (Cs) were compared for their ability to sensitise both parental and MDR cells to chemotherapeutic agents. Although 5-10-fold increases of sensitivity to anti-tumour drugs could be obtained for cells of the parental line with several Cs-derivatives, the largest 'gains' of sensitivity (chemosensitisation) were obtained for the cells of the MDR line and with only some of the Cs derivatives. The MDR cells employed displayed the typical MDR phenotype. However, we found no correlation between the immunosuppressive activity of Cs derivatives and their capacity to reverse MDR and all four possible combinations of these two activities could indeed be shown among the tested Cs derivatives. This study demonstrates for the first time that some immunosuppressive Cs can be devoid of chemosensitising activity. Nature Publishing Group 1989-12 /pmc/articles/PMC2247253/ /pubmed/2481487 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Gavériaux, C. Boesch, D. Boelsterli, J. J. Bollinger, P. Eberle, M. K. Hiestand, P. Payne, T. Traber, R. Wenger, R. Loor, F. Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives. |
title | Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives. |
title_full | Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives. |
title_fullStr | Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives. |
title_full_unstemmed | Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives. |
title_short | Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives. |
title_sort | overcoming multidrug resistance in chinese hamster ovary cells in vitro by cyclosporin a (sandimmune) and non-immunosuppressive derivatives. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247253/ https://www.ncbi.nlm.nih.gov/pubmed/2481487 |
work_keys_str_mv | AT gavariauxc overcomingmultidrugresistanceinchinesehamsterovarycellsinvitrobycyclosporinasandimmuneandnonimmunosuppressivederivatives AT boeschd overcomingmultidrugresistanceinchinesehamsterovarycellsinvitrobycyclosporinasandimmuneandnonimmunosuppressivederivatives AT boelsterlijj overcomingmultidrugresistanceinchinesehamsterovarycellsinvitrobycyclosporinasandimmuneandnonimmunosuppressivederivatives AT bollingerp overcomingmultidrugresistanceinchinesehamsterovarycellsinvitrobycyclosporinasandimmuneandnonimmunosuppressivederivatives AT eberlemk overcomingmultidrugresistanceinchinesehamsterovarycellsinvitrobycyclosporinasandimmuneandnonimmunosuppressivederivatives AT hiestandp overcomingmultidrugresistanceinchinesehamsterovarycellsinvitrobycyclosporinasandimmuneandnonimmunosuppressivederivatives AT paynet overcomingmultidrugresistanceinchinesehamsterovarycellsinvitrobycyclosporinasandimmuneandnonimmunosuppressivederivatives AT traberr overcomingmultidrugresistanceinchinesehamsterovarycellsinvitrobycyclosporinasandimmuneandnonimmunosuppressivederivatives AT wengerr overcomingmultidrugresistanceinchinesehamsterovarycellsinvitrobycyclosporinasandimmuneandnonimmunosuppressivederivatives AT loorf overcomingmultidrugresistanceinchinesehamsterovarycellsinvitrobycyclosporinasandimmuneandnonimmunosuppressivederivatives |